Early Detection Research Network

Triple Negative Breast Cancer Team Project

Triple negative breast cancers (TNBC), comprise 15-20% of breast cancers, and are associated with later stage at diagnosis, increased mortality, and occur more frequently in younger women where mammographic screening is less reliable. TNBCs are more likely to be diagnosed by physical exam than by mammographic screening. There is an unmet clinical need for biomarkers for the early detection of TNBC. Here, we are proposing the development of a plasma-based biomarker panel for the routine screening of women over the age of 40 for TNBC that can be used to identify women for further imaging.
333-triple-negative-breast-cancer-team-project
2d18076df80e43d59a8d4478636e8cde
2d18076df80e43d59a8d4478636e8cde
Contents

There are currently no items in this folder.